National and Kapodistrian University of Athens
Prognostic models for the evolution of melanocytic naevi
Abstract
dc:descriptionDual-Specificity Phosphatase 3 (DUSP3), also known as Vaccinia H1-related phosphatase, plays a critical role in regulating various cellular functions by dephosphorylating a broad range of substrates. Alterations in DUSP3’s expression and activity are implicated in the development and progression of various cancers, suggesting its potential as a therapeutic target. This work initially delves into DUSP3’s involvement in both benign and malignant melanocytic oncogenesis, emphasising on speculations regarding its regulatory effects on cellular processes such as growth, cell cycle progression, proliferation, survival, apoptosis, genomic stability/repair, adhesion, and migration of neoplastic melanocytes. Moreover, this study not only focuses on elucidating DUSP3’s role in melanocytic oncogenesis but also on investigating its potential as a diagnostic and prognostic biomarker by analyzing its post-translational levels. Therefore, immunohistochemistry was performed in 172 biopsied lesions from 130 individuals. The lesions were classified into four groups: common nevi (CN), dysplastic nevi (DN), and nevus and melanoma components of nevus-associated melanomas (N-NAMs and M-NAMs, respectively). Immunohistochemical staining and subsequent evaluation using the Immunoreactive Score (IRS) revealed a notable decrease in DUSP3’s positivity across M-NAMs compared to the nevus subgroups, with mean numerical IRS scores declining significantly from CN (7.5) to M-NAMs (1.9) (p<0.001). This decline in DUSP3’s expression suggests a potential role in the malignant transformation processes. The absence of strongly positive M-NAMs and the findings that 21.4% of M-NAMs developed from DUSP3-negative preexisting nevi while very few ones from strongly DUSP3-positive preexisting nevi further underscore DUSP3’s potential involvement in melanoma progression. Paired analysis of 84 matched NAM cases confirmed a significant reduction in DUSP3’s positivity in M-NAMs compared to N-NAMs (p<0.001). This reduction indicates that DUSP3 may serve as a marker for the transition from benign to malignant melanocytic lesions.Multivariate analysis revealed no significant differences in DUSP3’s expression among the nevus subgroups; however, a significant association was found when comparing these subgroups with M-NAMs, independent of sex and age. The odds of diagnosing any nevus type versus M-NAM increased significantly with each unit increase in the categorical IRS score (adjusted ORs: CN vs M-NAM: 11.333; DN vs M-NAM: 6.495; N-NAM vs M-NAM: 3.225, p<0.001). Additionally, analysis of CN and DN combined against N-NAMs produced an area under the Receiver Operating Characteristic curve of 0.716 (p<0.001), with an IRS score of 6 identified as the optimal cut-off (sensitivity: 60%, specificity: 80%), indicating DUSP3’s usefulness as a tool for the discrimination of a high-risk subgroup of nevi.Our findings demonstrate that high levels of DUSP3 are typically associated with benign melanocytic nevus tissues, whereas low or absent expression of DUSP3 is more commonly linked to melanocytic malignancy. Retention of DUSP3’s expression is rarely encountered among NAM’s tissues, validated by a significant likelihood for downgrade of the positivity category when comparing the N-NAM and M-NAM of the same tumour. Moreover, very few NAMs develop from a strongly positive preexisting nevus. The results also show that CN and DN share similar DUSP3’s expression profiles with NAM precursor nevi, supporting the view that DN are equally susceptible to malignant transformation also from the standpoint of DUSP3’s expression. Moreover, the heterogeneity of the DN diagnosis is further highlighted by the heterogeneity of DN’s expression of DUSP3. These underscore the need for additional criteria to accurately define the true melanoma precursor. Lastly, we propose the potential use of DUSP3 as an auxiliary biomarker for diagnosing challenging cases and discriminating nevi at a higher risk for malignant transformation, especially among individuals with high counts of nevi. All in all, the key position of DUSP3 within the spectrum of factors involved in melanocytic oncogenesis, as outlined by this study, highlights the necessity for further research towards this direction. This could enhance the precision of diagnosing and classifying benign melanocytic tumours, promote early detection and treatment of malignant ones, and ultimately lead to better patient outcomes.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chousakos, Emmanouil
- Χουσάκος, Εμμανουήλ
Subjects
dc:subject × 51- Μελάνωμα
- Σπίλος
- Δυσπλαστικός σπιλός
- Άτυπος σπίλος
- Ογκογένεση
- Ογκογενετική διαδικασία
- Μελανοκυτταρικές βλάβες
- Σπίλοι, Κοινοί μελανοκυτταρικοί
- Μελανοκυτταρικός
- Κακοήθες μελάνωμα
- Μελάνωμα δέρματος
- Ανοσοϊστοχημεία
- Ανοσοϊστοχημικές μέθοδοι
- Ανοσοϊστοχημικά ευρήματα
- Ανοσοϊστοχημικές τεχνικές
- Ανοσοϊστοχημική έκφραση
- Ανοσοϊστοχημική χρώση
- Ανοσοϊστοχημικοί δείκτες
- Ανοσοϊστοχημική μελέτη
- Φωσφατάση διπλής εξειδίκευσης
- Cutaneous melanoma
- Melanoma
- Melanoma cells
- Malignant melanoma
- Nevus
- Atypical nevus
- Acquired nevus
- Dysplastic nevus
- Dysplastic nevi
- Nevi
- Nevi, Common melanocutic
- Oncogenesis
- Melanocytic
- Melanocytic lesions
- Immunohistochemical expression
- Immunohistochemical markers
- Immunohistochemical method
- Immunohistochemic analysis
- Immunohistochemical methods
- Immunohistochemical staining
- Dual specificity phosphatase
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Παθολογοανατομία
- Κλινική Ιατρική
- Δερματολογία
- Basic Medicine
- Medical and Health Sciences
- Pathology
- Clinical Medicine
- Dermatology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60638